GlaxoSmithkline Consumer Healthcare has informed that a meeting of the Board of Directors of the Company will be held on August 05, 2015, to consider and take on record the Un-audited Financial Results for the quarter ended June 30, 2015 with Limited Review done by the Statutory Auditors.
The above information is a part of company’s filings submitted to BSE.